Aroflo (25 mcg+250 mcg)/puff (Inhaler)

120 metered doses: ৳ 850.00

Medicine Details

Product Title

  • Aroflo Inhaler

Categories

  • Medicine
  • Pharmaceuticals
  • Respiratory Health

Dosage Forms

  • Inhaler
  • Inhalation Capsule
  • Maxhaler

Dosage Options

  • 25 µg Salmeterol and 50 µg Fluticasone Propionate
  • 25 µg Salmeterol and 125 µg Fluticasone Propionate
  • 25 µg Salmeterol and 250 µg Fluticasone Propionate
  • 50 µg Salmeterol and 100 µg Fluticasone Propionate
  • 50 µg Salmeterol and 250 µg Fluticasone Propionate
  • 50 µg Salmeterol and 500 µg Fluticasone Propionate

Patient Age Groups

  • Adults and Adolescents 12 years and older:
    • Dosage options as per instructions
  • Children (4-12 years):
    • Dosage options as per instructions
  • Pediatric Patients (4 to 11 Years):
    • Dosage options as per instructions
  • Children (4 years and older):
    • Dosage options as per instructions

Mode of Action

  • Selective, long-acting beta-2 agonist used in the treatment of asthma
  • Corticosteroid with mainly glucocorticoid activity

Administration Instructions

  • Detailed steps for effective use of inhaler
  • Instructions for cleaning inhaler

Interaction Precautions

  • Avoid non-selective and selective β-blockers in patients with asthma
  • Careful co-administration with known strong CYP3A4 inhibitors

Contraindications

  • History of hypersensitivity to salmeterol xinafoate, fluticasone propionate or any excipients
  • Primary treatment of status asthmaticus or other acute episodes of asthma requiring intensive measures

Side Effects

  • Tremor, palpitations, headache, cardiac arrhythmia, arthralgia, rash, oedema, angioedema, oropharyngeal irritation, muscle cramps, hoarseness, candidiasis, cutaneous hypersensitivity reactions, facial and oropharyngeal oedema

Pregnancy & Lactation Precautions

  • Consideration of expected benefit to the mother vs possible risk to the fetus or child

Precautions & Warnings

  • Not suitable for relief of acute symptoms
  • Vigilance for pneumonia development in COPD patients
  • Monitoring for possible systemic effects including Cushing's syndrome, growth retardation, decrease in bone mineral density

Overdose Effects

  • Symptoms of overdose and respective treatment procedures for Salmeterol and Fluticasone Propionate

Therapeutic Class

  • Long-acting selective β-adrenoceptor stimulants
  • Respiratory corticosteroids

Storage Conditions

  • Pressurised canister, do not puncture or incinerate
  • Store below 30°C, away from sunlight, heat, and eyes

Related Brands